DocMorris Forecast, price target & analysts
DocMorris Target price 2025 - Analyst rating & recommendation
DocMorris Classifications & Recommendation:
DocMorris Price Target
| Target Price | CHF10.20 |
| Price | CHF6.43 |
| Potential |
58.63%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target DocMorris 2026 .
The average DocMorris target price is CHF10.20.
This is
58.63%
register free of charge
CHF20.68
221.64%
register free of charge
CHF8.08
25.66%
register free of charge
|
|
| A rating was issued by 15 analysts: 8 Analysts recommend DocMorris to buy, 5 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the DocMorris stock has an average upside potential 2026 of
58.63%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion CHF | 1.02 | 1.19 |
| 4.91% | 17.40% | |
| EBITDA Margin | -5.65% | -3.04% |
| 42.87% | 46.24% | |
| Net Margin | -9.56% | -29.80% |
| 212.66% | 211.65% |
11 Analysts have issued a sales forecast DocMorris 2025 . The average DocMorris sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an DocMorris EBITDA forecast 2025. The average DocMorris EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 DocMorris Analysts have issued a net profit forecast 2025. The average DocMorris net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | -4.06 | -7.03 |
| 217.00% | 73.15% | |
| P/E | negative | |
| EV/Sales | 0.47 |
11 Analysts have issued a DocMorris forecast for earnings per share. The average DocMorris EPS is
This results in the following potential growth metrics and future valuations:
Current DocMorris Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Apr 03 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| HSBC |
Locked
➜
Locked
|
Locked | Mar 23 2025 |
| RESEARCH PARTNERS AG |
Locked
➜
Locked
|
Locked | Mar 16 2025 |
| WARBURG RESEARCH GMBH |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Apr 03 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Apr 02 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
HSBC:
Locked
➜
Locked
|
Mar 23 2025 |
|
Locked
RESEARCH PARTNERS AG:
Locked
➜
Locked
|
Mar 16 2025 |
|
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
|
Mar 12 2025 |
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Mar 12 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
